TipRanks
Go Ultimate55% OFF

Enanta Pharmaceuticals (ENTA) Balance Sheet

Enanta Pharmaceuticals Balance Sheet

Enanta Pharmaceuticals's total assets for Q3 2026 were $296.87M, a decrease of 5.67% from the previous quarter. ENTA total liabilities were $195.80M for the fiscal quarter, a 1.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetSep 25Sep 24Sep 23Sep 22Sep 21
$ 280.73M$ 376.65M$ 462.27M$ 380.59M$ 440.86M
$ 216.01M$ 247.84M$ 245.54M$ 59.26M$ 41.43M
$ 64.72M$ 128.81M$ 216.74M$ 321.33M$ 399.43M

Currency in USD

Enanta Pharmaceuticals Debt to Assets

0200M400M600M0 %30 %60 %90 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets